Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.680
+0.020 (1.20%)
Dec 20, 2024, 4:00 PM EST - Market closed
Fate Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 191 | 369 | 980 | 5,587 | 7,933 | 1,479 | |
| Market Cap Growth | 90.75% | -62.39% | -82.45% | -29.57% | 436.26% | 78.48% | |
| Enterprise Value | -7 | 124 | 586 | 5,018 | 7,530 | 1,218 | |
| Last Close Price | 1.68 | 3.74 | 10.09 | 58.51 | 90.93 | 19.57 | |
| PS Ratio | 13.60 | 5.80 | 10.18 | 100.05 | 252.37 | 138.52 | |
| PB Ratio | 0.53 | 1.00 | 2.03 | 8.23 | 20.64 | 6.04 | |
| P/TBV Ratio | 1.10 | 1.00 | 2.03 | 8.23 | 20.64 | 6.04 | |
| EV/Sales Ratio | 14.45 | 1.95 | 6.09 | 89.85 | 239.54 | 114.02 | |
| Debt / Equity Ratio | 0.27 | 0.28 | 0.23 | 0.17 | 0.25 | 0.11 | |
| Asset Turnover | 0.03 | 0.10 | 0.12 | 0.07 | 0.07 | 0.04 | |
| Quick Ratio | 8.10 | 8.13 | 4.17 | 7.70 | 5.73 | 8.00 | |
| Current Ratio | 8.29 | 8.48 | 4.40 | 7.79 | 5.78 | 8.17 | |
| Return on Equity (ROE) | -46.59% | -37.76% | -48.46% | -39.90% | -55.11% | -48.44% | |
| Return on Assets (ROA) | -22.11% | -18.32% | -23.69% | -17.57% | -17.31% | -24.43% | |
| Return on Capital (ROIC) | -23.70% | -20.84% | -27.79% | -21.27% | -21.25% | -28.17% | |
| Earnings Yield | -93.15% | -43.64% | -28.73% | -3.80% | -2.19% | -6.63% | |
| FCF Yield | -69.26% | -37.53% | -28.94% | -3.82% | -0.56% | -6.12% | |
| Buyback Yield / Dilution | -11.03% | -1.64% | -2.19% | -15.01% | -20.82% | -21.35% | |
| Total Shareholder Return | -11.03% | -1.64% | -2.19% | -15.01% | -20.82% | -21.35% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.